{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T18:07:29Z","timestamp":1778350049881,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T00:00:00Z","timestamp":1355184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T00:00:00Z","timestamp":1355184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1038\/pr.2012.183","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T17:00:11Z","timestamp":1355245211000},"page":"286-293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Sertraline exposure leads to small left heart syndrome in adult mice"],"prefix":"10.1038","volume":"73","author":[{"given":"Sarah E.","family":"Haskell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory M.","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin E.","family":"Reinking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth A.","family":"Volk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica A.","family":"Peotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Roghair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,11]]},"reference":[{"key":"BFpr2012183_CR1","unstructured":"IMS Health. National Prescription Audit. Parsippany, NJ: IMS, 2010."},{"key":"BFpr2012183_CR2","doi-asserted-by":"publisher","first-page":"194.e1","DOI":"10.1016\/j.ajog.2007.07.036","volume":"198","author":"SE Andrade","year":"2008","unstructured":"Andrade SE, Raebel MA, Brown J, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008;198:194.e1\u20135.","journal-title":"Am J Obstet Gynecol"},{"key":"BFpr2012183_CR3","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1365-2125.2007.03048.x","volume":"65","author":"MK Bakker","year":"2008","unstructured":"Bakker MK, K\u00f6lling P, van den Berg PB, de Walle HE, de Jong van den Berg LT . Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. Br J Clin Pharmacol 2008;65:600\u20136.","journal-title":"Br J Clin Pharmacol"},{"key":"BFpr2012183_CR4","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/archpsyc.63.8.898","volume":"63","author":"TF Oberlander","year":"2006","unstructured":"Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C . Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 2006;63:898\u2013906.","journal-title":"Arch Gen Psychiatry"},{"key":"BFpr2012183_CR5","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1097\/JCP.0b013e31818b53fd","volume":"28","author":"CL Wichman","year":"2008","unstructured":"Wichman CL, Fothergill A, Moore KM, Lang TR, Heise RH Jr, Watson WJ . Recent trends in selective serotonin reuptake inhibitor use in pregnancy. J Clin Psychopharmacol 2008;28:714\u20136.","journal-title":"J Clin Psychopharmacol"},{"key":"BFpr2012183_CR6","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1176\/appi.ajp.160.5.993","volume":"160","author":"V Hendrick","year":"2003","unstructured":"Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D . Placental passage of antidepressant medications. Am J Psychiatry 2003;160:993\u20136.","journal-title":"Am J Psychiatry"},{"key":"BFpr2012183_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1001\/archpedi.160.2.173","volume":"160","author":"R Levinson-Castiel","year":"2006","unstructured":"Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G . Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006;160:173\u20136.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"BFpr2012183_CR8","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","volume":"293","author":"EL Moses-Kolko","year":"2005","unstructured":"Moses-Kolko EL, Bogen D, Perel J, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005;293:2372\u201383.","journal-title":"JAMA"},{"key":"BFpr2012183_CR9","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1056\/NEJMe078079","volume":"356","author":"MF Greene","year":"2007","unstructured":"Greene MF . Teratogenicity of SSRIs\u2013serious concern or much ado about little? N Engl J Med 2007;356:2732\u20133.","journal-title":"N Engl J Med"},{"key":"BFpr2012183_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1203\/00006450-200204000-00008","volume":"51","author":"TF Oberlander","year":"2002","unstructured":"Oberlander TF, Eckstein Grunau R, Fitzgerald C, et al. Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response. Pediatr Res 2002;51:443\u201353.","journal-title":"Pediatr Res"},{"key":"BFpr2012183_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.earlhumdev.2008.06.008","volume":"84","author":"TF Oberlander","year":"2008","unstructured":"Oberlander TF, Grunau R, Mayes L, et al. Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure. Early Hum Dev 2008;84:689\u201397.","journal-title":"Early Hum Dev"},{"key":"BFpr2012183_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1542\/peds.2004-0420","volume":"115","author":"TF Oberlander","year":"2005","unstructured":"Oberlander TF, Grunau RE, Fitzgerald C, Papsdorf M, Rurak D, Riggs W . Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics 2005;115:411\u201325.","journal-title":"Pediatrics"},{"key":"BFpr2012183_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1523\/JNEUROSCI.3973-07.2008","volume":"28","author":"MS Ansorge","year":"2008","unstructured":"Ansorge MS, Morelli E, Gingrich JA . Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci 2008;28:199\u2013207.","journal-title":"J Neurosci"},{"key":"BFpr2012183_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.biopsych.2008.09.026","volume":"65","author":"NA Shanahan","year":"2009","unstructured":"Shanahan NA, Holick Pierz KA, Masten VL, et al. Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice. Biol Psychiatry 2009;65:401\u20138.","journal-title":"Biol Psychiatry"},{"key":"BFpr2012183_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/sj.npp.1300823","volume":"31","author":"D Maciag","year":"2006","unstructured":"Maciag D, Simpson KL, Coppinger D, et al. Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 2006;31:47\u201357.","journal-title":"Neuropsychopharmacology"},{"key":"BFpr2012183_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neubiorev.2008.05.026","volume":"33","author":"E Nalivaiko","year":"2009","unstructured":"Nalivaiko E, Sgoifo A . Central 5-HT receptors in cardiovascular control during stress. Neurosci Biobehav Rev 2009;33:95\u2013106.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFpr2012183_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brainres.2009.03.044","volume":"1293","author":"JH Krystal","year":"2009","unstructured":"Krystal JH, Neumeister A . Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience. Brain Res 2009;1293:13\u201323.","journal-title":"Brain Res"},{"key":"BFpr2012183_CR18","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1056\/NEJMoa067407","volume":"356","author":"C Louik","year":"2007","unstructured":"Louik C, Lin AE, Werler MM, Hern\u00e1ndez-D\u00edaz S, Mitchell AA . First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 2007;356:2675\u201383.","journal-title":"N Engl J Med"},{"key":"BFpr2012183_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/CLEP.S9256","volume":"2","author":"JB Kornum","year":"2010","unstructured":"Kornum JB, Nielsen RB, Pedersen L, Mortensen PB, N\u00f8rgaard M . Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis. Clin Epidemiol 2010;2:29\u201336.","journal-title":"Clin Epidemiol"},{"key":"BFpr2012183_CR20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/bdra.20615","volume":"85","author":"P Merlob","year":"2009","unstructured":"Merlob P, Birk E, Sirota L, et al. Are selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmur. Birth Defects Res Part A Clin Mol Teratol 2009;85:837\u201341.","journal-title":"Birth Defects Res Part A Clin Mol Teratol"},{"key":"BFpr2012183_CR21","doi-asserted-by":"publisher","first-page":"b3569","DOI":"10.1136\/bmj.b3569","volume":"339","author":"LH Pedersen","year":"2009","unstructured":"Pedersen LH, Henriksen TB, Vestergaard M, Olsen J, Bech BH . Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 2009;339:b3569.","journal-title":"BMJ"},{"key":"BFpr2012183_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ijdevneu.2003.10.002","volume":"21","author":"Y Sari","year":"2003","unstructured":"Sari Y, Zhou FC . Serotonin and its transporter on proliferation of fetal heart cells. Int J Dev Neurosci 2003;21:417\u201324.","journal-title":"Int J Dev Neurosci"},{"key":"BFpr2012183_CR23","doi-asserted-by":"publisher","first-page":"e2782","DOI":"10.1371\/journal.pone.0002782","volume":"3","author":"CW Noorlander","year":"2008","unstructured":"Noorlander CW, Ververs FF, Nikkels PG, van Echteld CJ, Visser GH, Smidt MP . Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities. PLoS ONE 2008;3:e2782.","journal-title":"PLoS ONE"},{"key":"BFpr2012183_CR24","first-page":"571","volume":"50","author":"FJ Clubb Jr","year":"1984","unstructured":"Clubb FJ Jr, Bishop SP . Formation of binucleated myocardial cells in the neonatal rat. An index for growth hypertrophy. Lab Invest 1984;50:571\u20137.","journal-title":"Lab Invest"},{"key":"BFpr2012183_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/cvr\/cvq005","volume":"86","author":"S Walsh","year":"2010","unstructured":"Walsh S, Pont\u00e9n A, Fleischmann BK, Jovinge S . Cardiomyocyte cell cycle control and growth estimation in vivo\u2013an analysis based on cardiomyocyte nuclei. Cardiovasc Res 2010;86:365\u201373.","journal-title":"Cardiovasc Res"},{"key":"BFpr2012183_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijcard.2009.09.543","volume":"141","author":"JF Thayer","year":"2010","unstructured":"Thayer JF, Yamamoto SS, Brosschot JF . The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol 2010;141:122\u201331.","journal-title":"Int J Cardiol"},{"key":"BFpr2012183_CR27","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/00005344-200006000-00004","volume":"35","author":"Z Ungvari","year":"2000","unstructured":"Ungvari Z, Pacher P, Koller A . Serotonin reuptake inhibitor fluoxetine decreases arteriolar myogenic tone by reducing smooth muscle [Ca2+]i. J Cardiovasc Pharmacol 2000;35:849\u201354.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFpr2012183_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.molmed.2004.03.007","volume":"10","author":"F C\u00f4t\u00e9","year":"2004","unstructured":"C\u00f4t\u00e9 F, Fligny C, Fromes Y, Mallet J, Vodjdani G . Recent advances in understanding serotonin regulation of cardiovascular function. Trends Mol Med 2004;10:232\u20138.","journal-title":"Trends Mol Med"},{"key":"BFpr2012183_CR29","doi-asserted-by":"publisher","first-page":"9508","DOI":"10.1073\/pnas.97.17.9508","volume":"97","author":"CG Nebigil","year":"2000","unstructured":"Nebigil CG, Choi DS, Dierich A, et al. Serotonin 2B receptor is required for heart development. Proc Natl Acad Sci USA 2000;97:9508\u201313.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFpr2012183_CR30","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1161\/01.CIR.103.24.2973","volume":"103","author":"CG Nebigil","year":"2001","unstructured":"Nebigil CG, Hickel P, Messaddeq N, et al. Ablation of serotonin 5-HT(2B) receptors in mice leads to abnormal cardiac structure and function. Circulation 2001;103:2973\u20139.","journal-title":"Circulation"},{"key":"BFpr2012183_CR31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0091-3057(01)00701-8","volume":"71","author":"M Brocco","year":"2002","unstructured":"Brocco M, Dekeyne A, Veiga S, Girardon S, Millan MJ . Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents. Pharmacol Biochem Behav 2002;71:667\u201380.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFpr2012183_CR32","doi-asserted-by":"publisher","first-page":"431574","DOI":"10.1155\/2012\/431574","volume":"2012","author":"GJ Kummet","year":"2012","unstructured":"Kummet GJ, Haskell SE, Hermann GM, et al. Neonatal SSRI exposure programs a hypermetabolic state in adult mice. J Nutr Metab 2012;2012:431574.","journal-title":"J Nutr Metab"},{"key":"BFpr2012183_CR33","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1542\/peds.113.2.368","volume":"113","author":"PS Zeskind","year":"2004","unstructured":"Zeskind PS, Stephens LE . Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 2004;113:368\u201375.","journal-title":"Pediatrics"},{"key":"BFpr2012183_CR34","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s11064-008-9818-2","volume":"34","author":"K Muneoka","year":"2009","unstructured":"Muneoka K, Shirayama Y, Takigawa M, Shioda S . Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats. Neurochem Res 2009;34:542\u201355.","journal-title":"Neurochem Res"},{"key":"BFpr2012183_CR35","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1038\/npp.2009.29","volume":"34","author":"AL Halberstadt","year":"2009","unstructured":"Halberstadt AL, van der Heijden I, Ruderman MA, et al. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice. Neuropsychopharmacology 2009;34:1958\u201367.","journal-title":"Neuropsychopharmacology"},{"key":"BFpr2012183_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.pbiomolbio.2010.11.010","volume":"106","author":"K Thornburg","year":"2011","unstructured":"Thornburg K, Jonker S, O\u2019Tierney P, et al. Regulation of the cardiomyocyte population in the developing heart. Prog Biophys Mol Biol 2011;106:289\u201399.","journal-title":"Prog Biophys Mol Biol"},{"key":"BFpr2012183_CR37","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1126\/science.1164680","volume":"324","author":"O Bergmann","year":"2009","unstructured":"Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science 2009;324:98\u2013102.","journal-title":"Science"},{"key":"BFpr2012183_CR38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/jat\/31.7.409","volume":"31","author":"RD Johnson","year":"2007","unstructured":"Johnson RD, Lewis RJ, Angier MK . The distribution of fluoxetine in human fluids and tissues. J Anal Toxicol 2007;31:409\u201314.","journal-title":"J Anal Toxicol"},{"key":"BFpr2012183_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/FTD.0b013e31819114ea","volume":"31","author":"M Reis","year":"2009","unstructured":"Reis M, Aamo T, Spigset O, Ahlner J . Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database. Ther Drug Monit 2009;31:42\u201356.","journal-title":"Ther Drug Monit"},{"key":"BFpr2012183_CR40","first-page":"297","volume":"100","author":"RH Kelly","year":"2002","unstructured":"Kelly RH, Russo J, Holt VL, et al. Psychiatric and substance use disorders as risk factors for low birth weight and preterm delivery. Obstet Gynecol 2002;100:297\u2013304.","journal-title":"Obstet Gynecol"},{"key":"BFpr2012183_CR41","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440\u201363.","journal-title":"J Am Soc Echocardiogr"},{"key":"BFpr2012183_CR42","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1161\/01.CIR.60.6.1308","volume":"60","author":"G Kronik","year":"1979","unstructured":"Kronik G, Slany J, M\u00f6sslacher H . Comparative value of eight M-mode echocardiographic formulas for determining left ventricular stroke volume. A correlative study with thermodilution and left ventricular single-plane cineangiography. Circulation 1979;60:1308\u201316.","journal-title":"Circulation"},{"key":"BFpr2012183_CR43","doi-asserted-by":"publisher","first-page":"R651","DOI":"10.1152\/ajpregu.90756.2008","volume":"296","author":"RD Roghair","year":"2009","unstructured":"Roghair RD, Segar JL, Volk KA, et al. Vascular nitric oxide and superoxide anion contribute to sex-specific programmed cardiovascular physiology in mice. Am J Physiol Regul Integr Comp Physiol 2009;296:R651\u201362.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFpr2012183_CR44","unstructured":"Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996;93:1043\u201365."},{"key":"BFpr2012183_CR45","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1440-1681.2007.04588.x","volume":"34","author":"HM Stauss","year":"2007","unstructured":"Stauss HM . Identification of blood pressure control mechanisms by power spectral analysis. Clin Exp Pharmacol Physiol 2007;34:362\u20138.","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2012183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2012183","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2012183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:56:38Z","timestamp":1684472198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2012183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,11]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["BFpr2012183"],"URL":"https:\/\/doi.org\/10.1038\/pr.2012.183","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,11]]},"assertion":[{"value":"31 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}